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In the molecule of the title compound, C7H9ClN2O2, the
conformation is determined by intramolecular C—H  O and
C—H  Cl hydrogen bonds, which generate S(6) and S(5) ring
motifs. The isopropyl group is almost perpendicular to the
pyrimidine ring with torsion angles of 70.8 (3) and 56.0 (3).
In the crystal, two inversion-related molecules are linked via a
pair of N—H  O hydrogen bonds into R22(8) dimers; these
dimers are connected into chains extending along the bc plane
via an additional N—H  O hydrogen bond and weaker C—
H  O hydrogen bonds. The crystal structure is further
stabilized by a weak – interaction [3.6465 (10) A˚] between
adjacent pyrimidine-dione rings arranged in a head-to-tail
fashion, producing a three-dimensional network.




For the biological activity of pyrimidine-2,4(1H,3H)-diones,
see: Miyasaka et al. (1989); Tanaka et al. (1995); Hopkins et al.
(1996); El-Brollosy et al. (2009); Klein et al. (2001); Nencka et
al. (2006); El-Emam et al. (2004). For the use of 5-alkyl-6-
chloropyrimidine-2,4(1H,3H)-diones in synthesis, see: El-
Emam et al. (2004). For related pyrimidine-2,4-dione struc-
tures, see: El-Brollosy et al. (2011); Al-Omary et al. (2014);
Haress et al. (2014). For the synthesis of the title compound,
see: Al-Turkistani et al. (2011); Koroniak et al. (1993). For






a = 11.2244 (4) A˚
b = 6.8288 (3) A˚
c = 11.6641 (5) A˚
 = 104.577 (2)
V = 865.26 (6) A˚3
Z = 4
Cu K radiation
 = 3.62 mm1
T = 296 K






Tmin = 0.292, Tmax = 0.458
5647 measured reflections
1553 independent reflections
1444 reflections with I > 2(I)
Rint = 0.027
2.3. Refinement
R[F 2 > 2(F 2)] = 0.040




H atoms treated by a mixture of
independent and constrained
refinement
max = 0.27 e A˚
3
min = 0.32 e A˚3
Table 1
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
N1—H1N1  O1i 0.83 (3) 2.01 (3) 2.833 (2) 169 (2)
N2—H1N2  O2ii 0.83 (3) 2.03 (3) 2.854 (2) 171 (2)
C5—H5  Cl1 0.94 (3) 2.57 (2) 3.132 (2) 118.7 (17)
C6—H6A  O1iii 0.96 2.56 3.455 (3) 156
C6—H6B  O2 0.96 2.45 3.034 (3) 119
Symmetry codes: (i) xþ 1; yþ 12;zþ 12; (ii) xþ 1;y;zþ 1; (iii)x þ 1;yþ 1;zþ 1.
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
SHELXTL (Sheldrick, 2008); software used to prepare material for
publication: SHELXTL and PLATON (Spek, 2009).
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S1. Comment 
Pyrimidine-2,4-diones and their related derivatives have long been known for their diverse chemotherapeutic activities 
including antiviral activity against HIV (Miyasaka et al., 1989; Tanaka et al., 1995; Hopkins et al., 1996; El-Emam et al., 
2004). In addition, potent anticancer activity was observed for several pyrimidine-2,4-diones (Klein et al., 2001; Nencka 
et al., 2006). In a continuation of our interest in the chemical and pharmacological properties of pyrimidine and uracil 
derivatives (Al-Omary et al., 2014; Haress et al., 2014, El-Brollosy et al., 2009), we have synthesized the title compound 
(I) as a precursor to the synthesis of a potential chemotherapeutic agent (Al-Turkistani et al., 2011).
In the title compound (Fig. 1), the molecular conformation is stabilized by intramolecular C6–H6B···O2 and C5–
H5···Cl1 hydrogen bonds incorporating S(6) and S(5) ring motifs respectively (Bernstein et al., 1995). The isopropyl 
group is almost perpendicular to the N1/N2/C1–C4 ring with the C3–C4–C5–C7 and C3–C4–C5–C6 torsion angles of 
-70.8 (3)° and 56.0 (3)° respectively. In the crystal structure, two adjacent molecules are linked via a pair of N2–
H1N2···O2 intermolecular hydrogen bonds forming inversion related R22(8) dimers (Fig. 2).; these dimers are connected 
into chains via N1–H1N1···O1 and weak C6–H6A···O1 hydrogen bonds extending along the bc plane. The crystal 
structure is further stabilized by a weak π···π interaction [3.6465 (10) Å] producing a three-dimensional network.
S2. Experimental 
5-Isopropylbarbituric acid (8.51 g, 0.05 mol) was added portionwise with stirring to a mixture of phosphorus oxychloride 
(19.2 ml) and N,N-dimethyl aniline (10.3 ml) over a period of 10 minutes. The mixture was then heated under reflux for 
one hour. On cooling, the mixture was poured onto crushed ice (200 g m), stirred for 30 minutes and extracted with di-
ethyl ether (400 ml). The ethereal extract was dried over anhydrous sodium sulfate and evaporated under vacuum at room 
temperature to yield the intermediate 5-isopropyl-2,4,6-trichloropyrimidine as a white waxy solid. 10% Sodium 
hydroxide (20 ml) was then added to the intermediate and the mixture was heated under reflux for 30 minutes. On 
cooling, the mixture was acidified with hydrochloric acid to pH 1–2 and the separated precipitate was filtered, washed 
with cold water and crystallized from ethanol to yield 6.98 g (74%) of the title compound (C7H9ClN2O2) as colourless 
crystals. M.P.: 257–259 °C.
1H NMR (DMSO-d6, 500.13 MHz): δ 1.14 (d, 6H, CH3, J = 7.2 Hz), 2.51–2.63 (m, 1H, CH), 11.22 (s, 1H, NH), 11.79 
(s, 1H, NH). 13C NMR (DMSO-d6, 125.76 MHz): δ 20.02 (CH3), 26.52 (CH), 113.95 (C–5), 140.95 (C-6), 149.75 (C=O), 
162.75 (C=O).
S3. Refinement 
The nitrogen-bound H-atoms were located in a difference Fourier map and were refined freely [N–H 0.83 (2) and 0.84 (3) 
Å]. Other H atoms were positioned geometrically (C=H 0.95–0.96 Å) and refined using a riding model with Uiso(H) = 1.2 
supporting information
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Ueq(C) or 1.5 Ueq(C) for methyl H atoms. A rotating group model was used for the methyl groups.
Figure 1
The molecular structure of the title compound with atom labels and 30% probability displacement ellipsoids. 
supporting information
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Figure 2
Crystal packing of the title compound, showing the hydrogen bonding interactions as dashed lines. H-atoms not involved 






Hall symbol: -P 2ybc
a = 11.2244 (4) Å
b = 6.8288 (3) Å
c = 11.6641 (5) Å
β = 104.577 (2)°
V = 865.26 (6) Å3
Z = 4
F(000) = 392
Dx = 1.448 Mg m−3
Cu Kα radiation, λ = 1.54178 Å
Cell parameters from 3341 reflections
θ = 3.9–69.4°
µ = 3.62 mm−1
T = 296 K
Block, colourless
0.45 × 0.28 × 0.26 mm
Data collection 
Bruker APEXII CCD 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 2009)
Tmin = 0.292, Tmax = 0.458
5647 measured reflections
1553 independent reflections
1444 reflections with I > 2σ(I)
Rint = 0.027















Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo2) + (0.0664P)2 + 0.3263P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.27 e Å−3
Δρmin = −0.32 e Å−3
Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Extinction coefficient: 0.0181 (15)
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
Cl1 0.20279 (5) 0.71985 (9) 0.34179 (6) 0.0644 (3)
O1 0.55744 (12) 0.3674 (2) 0.28760 (12) 0.0465 (4)
O2 0.35879 (13) 0.0719 (2) 0.53323 (13) 0.0522 (4)
N1 0.39383 (14) 0.5227 (2) 0.32786 (14) 0.0386 (4)
N2 0.45727 (14) 0.2261 (2) 0.41291 (14) 0.0394 (4)
C1 0.29636 (16) 0.5181 (3) 0.37878 (16) 0.0371 (4)
C2 0.47498 (15) 0.3710 (3) 0.33892 (15) 0.0354 (4)
C3 0.36295 (16) 0.2134 (3) 0.46972 (15) 0.0371 (4)
C4 0.27390 (15) 0.3729 (3) 0.44806 (15) 0.0368 (4)
C5 0.16037 (17) 0.3635 (3) 0.49593 (17) 0.0437 (5)
C6 0.1871 (2) 0.3338 (5) 0.6280 (2) 0.0697 (7)
H6A 0.2438 0.4322 0.6675 0.105*
H6B 0.2226 0.2065 0.6480 0.105*
H6C 0.1119 0.3437 0.6527 0.105*
C7 0.0719 (2) 0.2127 (5) 0.4302 (3) 0.0815 (9)
H7A 0.0568 0.2355 0.3465 0.122*
H7B −0.0041 0.2217 0.4533 0.122*
H7C 0.1065 0.0845 0.4486 0.122*
H1N1 0.403 (2) 0.617 (4) 0.2856 (19) 0.043 (6)*
H1N2 0.506 (2) 0.132 (4) 0.422 (2) 0.059 (7)*
H5 0.125 (2) 0.489 (4) 0.481 (2) 0.058 (7)*
supporting information
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Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
Cl1 0.0662 (4) 0.0486 (4) 0.0892 (5) 0.0249 (2) 0.0395 (3) 0.0243 (3)
O1 0.0481 (7) 0.0421 (8) 0.0587 (9) 0.0001 (6) 0.0307 (6) −0.0012 (6)
O2 0.0522 (8) 0.0506 (9) 0.0614 (9) 0.0157 (6) 0.0286 (6) 0.0227 (7)
N1 0.0458 (8) 0.0321 (8) 0.0424 (9) 0.0018 (6) 0.0197 (7) 0.0042 (6)
N2 0.0394 (8) 0.0381 (8) 0.0451 (9) 0.0095 (7) 0.0187 (7) 0.0061 (6)
C1 0.0392 (9) 0.0358 (9) 0.0379 (10) 0.0053 (7) 0.0124 (7) −0.0011 (7)
C2 0.0373 (8) 0.0343 (9) 0.0365 (9) −0.0012 (7) 0.0129 (7) −0.0044 (7)
C3 0.0376 (9) 0.0394 (10) 0.0361 (10) 0.0033 (7) 0.0125 (7) 0.0025 (7)
C4 0.0380 (9) 0.0393 (10) 0.0346 (9) 0.0044 (7) 0.0120 (7) 0.0005 (7)
C5 0.0420 (9) 0.0460 (11) 0.0485 (11) 0.0095 (8) 0.0215 (8) 0.0060 (8)
C6 0.0585 (13) 0.108 (2) 0.0512 (14) 0.0016 (14) 0.0296 (11) −0.0019 (13)
C7 0.0472 (13) 0.120 (3) 0.0849 (19) −0.0208 (14) 0.0314 (13) −0.0335 (17)
Geometric parameters (Å, º) 
Cl1—C1 1.7200 (18) C4—C5 1.516 (2)
O1—C2 1.222 (2) C5—C7 1.500 (3)
O2—C3 1.226 (2) C5—C6 1.507 (3)
N1—C2 1.364 (2) C5—H5 0.95 (3)
N1—C1 1.370 (2) C6—H6A 0.9600
N1—H1N1 0.83 (2) C6—H6B 0.9600
N2—C2 1.360 (2) C6—H6C 0.9600
N2—C3 1.386 (2) C7—H7A 0.9600
N2—H1N2 0.84 (3) C7—H7B 0.9600
C1—C4 1.342 (3) C7—H7C 0.9600
C3—C4 1.457 (2)
C2—N1—C1 121.92 (16) C7—C5—C6 111.5 (2)
C2—N1—H1N1 117.6 (15) C7—C5—C4 110.49 (17)
C1—N1—H1N1 120.4 (15) C6—C5—C4 114.38 (17)
C2—N2—C3 126.87 (16) C7—C5—H5 109.6 (16)
C2—N2—H1N2 116.1 (17) C6—C5—H5 106.3 (15)
C3—N2—H1N2 116.9 (17) C4—C5—H5 104.3 (15)
C4—C1—N1 124.69 (16) C5—C6—H6A 109.5
C4—C1—Cl1 123.17 (14) C5—C6—H6B 109.5
N1—C1—Cl1 112.13 (13) H6A—C6—H6B 109.5
O1—C2—N2 123.07 (17) C5—C6—H6C 109.5
O1—C2—N1 122.60 (17) H6A—C6—H6C 109.5
N2—C2—N1 114.32 (15) H6B—C6—H6C 109.5
O2—C3—N2 119.22 (16) C5—C7—H7A 109.5
O2—C3—C4 124.43 (16) C5—C7—H7B 109.5
N2—C3—C4 116.35 (16) H7A—C7—H7B 109.5
C1—C4—C3 115.60 (16) C5—C7—H7C 109.5
C1—C4—C5 123.76 (16) H7A—C7—H7C 109.5
C3—C4—C5 120.54 (16) H7B—C7—H7C 109.5
supporting information
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C2—N1—C1—C4 3.4 (3) N1—C1—C4—C5 −175.22 (17)
C2—N1—C1—Cl1 −175.53 (14) Cl1—C1—C4—C5 3.6 (3)
C3—N2—C2—O1 −176.48 (18) O2—C3—C4—C1 177.94 (19)
C3—N2—C2—N1 4.4 (3) N2—C3—C4—C1 −2.5 (2)
C1—N1—C2—O1 175.02 (17) O2—C3—C4—C5 −5.7 (3)
C1—N1—C2—N2 −5.8 (2) N2—C3—C4—C5 173.89 (16)
C2—N2—C3—O2 179.34 (18) C1—C4—C5—C7 105.3 (2)
C2—N2—C3—C4 −0.3 (3) C3—C4—C5—C7 −70.8 (3)
N1—C1—C4—C3 1.0 (3) C1—C4—C5—C6 −128.0 (2)
Cl1—C1—C4—C3 179.85 (13) C3—C4—C5—C6 56.0 (3)
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
N1—H1N1···O1i 0.83 (3) 2.01 (3) 2.833 (2) 169 (2)
N2—H1N2···O2ii 0.83 (3) 2.03 (3) 2.854 (2) 171 (2)
C5—H5···Cl1 0.94 (3) 2.57 (2) 3.132 (2) 118.7 (17)
C6—H6A···O1iii 0.96 2.56 3.455 (3) 156
C6—H6B···O2 0.96 2.45 3.034 (3) 119
Symmetry codes: (i) −x+1, y+1/2, −z+1/2; (ii) −x+1, −y, −z+1; (iii) −x+1, −y+1, −z+1.
